US diplomat meets COAS for 2nd time in a month
RAWALPINDI: Ms Angela Aggeler, US charge d’ affairs to Pakistan, held the second meeting in a month with General Qamar Javed Bajwa, Chief of Army Staff (COAS), here at GHQ on Friday. During the meeting, matters of mutual interest, overall regional security situation including recent developments in Afghan peace process and bilateral cooperation in various fields were discussed. The senior US diplomat appreciated Pakistan’s sincere efforts for bringing peace and stability in the region, especially the Afghan peace process.
Earlier, General Sir Nicholas Patrick, the chief of defence of UK, also met the COAS at GHQ on 10th of this month to discuss developments regarding Afghan peace process prior to their visit to Kabul, the same day. Just two days later, on May 12, the US charge d’ affairs called on General Bajwa at GHQ.
-
Savannah Guthrie Expresses Fresh Hope As Person Detained For Questioning Over Kidnapping Of Nancy -
ByteDance Suspends Viral Seedance 2.0 Photo-to-voice Feature: Here’s Why -
Tom Hanks Diabetes 2 Management Strategy Laid Bare -
Bad Bunny Wins Hearts With Sweet Gesture At Super Bowl Halftime Show -
Why Angelina Jolie Loves Her 'scars' Following Double Mastectomy -
‘World Is In Peril’: Anthropic AI Safety Researcher Resigns, Warns Of Global Risks -
Meghan Markle Receives Apology As Andrew Puts Monarchy In Much Bigger Scandal -
Catherine O’Hara Becomes Beacon Of Hope For Rectal Cancer Patients -
Nancy Guthrie: Is She Alive? Former FBI Director Shares Possibilities On 10th Day Of Kidnapping -
Siemens Energy Profit Surges Nearly Threefold Amid AI Boom For Gas Turbines, Grids -
TikTok's ByteDance To Develop Advance AI Chips With Samsung -
Princess Beatrice, Eugenie In Dilemma As Andrew, Fergie Scandal Continues -
Tumbler Ridge School Shooting Among Canada’s Deadliest — Here’s Where It Ranks -
Suspect Detained As Authorities Probe Nancy Guthrie’s Abduction -
Tumbler Ridge Tragedy: Nine Killed, 25 Injured After School Shooting In British Columbia -
FDA Sends 'refusal-to-file' To Moderna Over New Flu Vaccine